ScholarIQanswers from OpenAlex & ORCID
Garrett M. Frampton
ResearcherPublications, citations & collaboration network
Garrett M. Frampton is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Garrett M. Frampton have?
ScholarIQindexed works
Garrett M. Frampton has 674 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Garrett M. Frampton have?
ScholarIQcitation count
Garrett M. Frampton has 44,490 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Garrett M. Frampton?
ScholarIQh-index
Garrett M. Frampton has an h-index of 86 in OpenAlex.
What is the i10-index of Garrett M. Frampton?
ScholarIQi10-index
Garrett M. Frampton has an i10-index of 180 in OpenAlex.
What is the ORCID of Garrett M. Frampton?
ScholarIQorcid
The ORCID for Garrett M. Frampton is on the source record.
What is the OpenAlex record for Garrett M. Frampton?
ScholarIQopenalex
The OpenAlex for Garrett M. Frampton is on the source record.
What are the most-cited papers on Garrett M. Frampton?
ScholarIQmost cited works
Histone H3K27ac separates active from poised enhancers and predicts developmental state
Menno P. Creyghton, Albert W. Cheng, G. Grant Welstead, Tristan Kooistra, Bryce W. Carey, Eveline J. Steine, Jacob H. Hanna, Michael A. Lodato, Garrett M. Frampton, Phillip A. Sharp, Laurie A. Boyer, Richard A. Young, Rudolf Jaenisch
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Zachary R. Chalmers, Caitlin Connelly, David Fabrizio, Laurie M. Gay, Siraj M. Ali, Riley Ennis, Alexa B. Schrock, Brittany Campbell, Adam Shlien, Juliann Chmielecki, Franklin W. Huang, Yuting He, James Sun, Uri Tabori, Mark Kennedy, Daniel S. Lieber, Steven Roels, Jared White, Geoffrey A. Otto, Jeffrey S. Ross, Levi A. Garraway, Vincent A. Miller, P. J. Stephens, Garrett M. Frampton
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
Jonathan E. Rosenberg, Jean Hoffman‐Censits, Tom Powles, Michiel S. van der Heijden, Arjun Vasant Balar, Andrea Necchi, Nancy A. Dawson, Peter H. O’Donnell, Ani Sarkis Balmanoukian, Yohann Loriot, Sandy Srinivas, Margitta Retz, Petros Grivas, Richard W. Joseph, Matthew D. Galsky, Mark T. Fleming, Daniel P. Petrylak, José Luis Perez‐Gracia, Howard A. Burris, Daniel Castellano, Christina Canil, Joaquim Bellmunt, Dean F. Bajorin, Dorothee Nickles, Richard Bourgon, Garrett M. Frampton, Na Cui, Sanjeev Mariathasan, Oyewale O. Abidoye, Gregg Fine, Robert Dreicer
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
Aaron M. Goodman, Shumei Kato, Lyudmila Bazhenova, Sandip Pravin Patel, Garrett M. Frampton, Vincent A. Miller, Philip J. Stephens, Gregory A. Daniels, Razelle Kurzrock
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
Garrett M. Frampton, Alex Fichtenholtz, Geoff Otto, Kai Wang, Sean R. Downing, Jie He, Michael Schnall-Levin, Jared White, Eric M. Sanford, Peter An, James Sun, Frank Juhn, Kristina Brennan, Kiel Iwanik, Ashley Maillet, Jamie Buell, Emily White, Mandy Zhao, Sohail Balasubramanian, Selmira Terzic, Tina Richards, Vera Banning, Lázaro Ibrahim Romero García, Kristen Mahoney, Zac Zwirko, Amy Donahue, Himisha Beltran, Juan Miguel Mosquera, Mark A. Rubin, Snjezana Doğan, Cyrus V. Hedvat, Michael F. Berger, Lajos Pusztai, Matthias Lechner, Chris Boshoff, Mirna Jarosz, Christine Vietz, Alex Parker, Vincent A. Miller, Jeffrey S. Ross, John A. Curran, Maureen Cronin, Philip J. Stephens, Doron Lipson, Roman Yelensky